Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling cold or getting chills on Mounjaro is reported by some people, particularly in the first weeks of treatment or after a dose increase. It is not listed among the most common side effects in Mounjaro's licensed product information, but it does come up — often linked to the same GI effects and appetite changes that tirzepatide is known for. These are prescription-only medicines; a clinical assessment determines whether Mounjaro is right for you, and any side effects that concern you should be discussed with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The decision most people face when they notice chills on Mounjaro is whether they're experiencing a predictable, self-limiting response or something worth escalating. The honest answer is: it depends on what else is going on.
Tirzepatide works partly by significantly reducing appetite and slowing how quickly food leaves the stomach. When calorie intake drops sharply, the body produces less heat, the metabolic equivalent of turning the thermostat down. This is not unique to Mounjaro; it happens with other GLP-1 medicines and with calorie restriction generally. For some people it feels like a persistent chill, or a sensitivity to cold rooms that wasn't there before treatment started. If you want a fuller explanation of why this happens, the page on whether Mounjaro can give you chills walks through the mechanisms in more detail.
A second route to chills is dehydration. Nausea, vomiting and diarrhoea are the most commonly reported side effects of tirzepatide, particularly in the first few weeks or after stepping up a dose. Fluid loss from GI side effects can make you feel shivery and run-down even without a raised temperature. One quick check worth doing: pinch the skin on the back of your hand and release it, if it doesn't spring back promptly, drink water before anything else.
It's also worth ruling out something unrelated. Colds, flu and other infections can coincide with starting any new medicine. If chills come with a fever, a sore throat or muscle aches, that's more likely an infection than a drug effect, see your GP rather than adjusting your Mounjaro.
Most reports of Mounjaro cold chills are mild and short-lived. The ones that need urgent attention look different.
In January 2026 the MHRA issued a Drug Safety Update reminding patients and clinicians that acute pancreatitis is a known, infrequent but serious risk with GLP-1 medicines including tirzepatide. The key symptom is severe, persistent stomach pain (often described as a deep ache that reaches through to the back) sometimes with vomiting. If chills arrive alongside pain like that, do not wait to see if it settles: go to A&E or call 999.
Signs of significant dehydration also warrant prompt action: a very dry mouth, dizziness when standing, passing little or no urine, or feeling faint. These can strain the kidneys and should be assessed the same day. You can read the full patient-level safety information on the NHS tirzepatide medicines page, which covers when to seek help.
For everything milder (a cold feeling that is inconvenient but manageable, or chills that come and go without other symptoms) the right move is to log what you notice and raise it at your next prescriber check-in. Your prescriber may want to review your dose timing, your hydration, or whether the titration schedule needs adjusting.
Those considering Mounjaro who want to understand the full cost picture before starting can find a straightforward breakdown on the Mounjaro price comparison page.
If you are currently on Mounjaro and experiencing chills, here is a practical framework before your next conversation with a clinician.
First, track the pattern. Are chills appearing on injection day, or a day or two later when GI effects typically peak? That timing points toward the drug effect rather than something else. Are they getting better week on week? That suggests the adjustment phase most people move through. Are they getting worse? That's the signal to contact your prescriber sooner rather than later.
Second, support your body. Eating enough protein is harder when appetite drops, but protein helps maintain muscle and warmth. Small, frequent meals tend to be better tolerated than larger ones during the titration phase. Staying well hydrated matters, nausea can make drinking feel unappealing, but sipping plain water steadily through the day helps.
Third, don't adjust your dose yourself. It can be tempting to stay on a lower dose if you are feeling cold or unwell, but any change to your titration schedule should go through your prescriber. The Mounjaro treatment page explains how the dose schedule works and what the prescriber reviews at each stage. For a broader look at what injectable weight-loss treatment involves, the weight-loss treatment overview covers the key questions.
People who are also taking oral contraceptives should be aware that tirzepatide can reduce pill absorption in the first four weeks of treatment and for four weeks after each dose increase, your prescriber can advise on additional contraception if needed, and there is more detail on how Mounjaro affects birth control pills. If you are exploring whether an oral GLP-1 option might suit you better, the Mounjaro pills page explains what is and isn't available.
Contact the team that prescribed your Mounjaro if chills are: present most days for more than two weeks; getting worse rather than better; accompanied by any of the urgent symptoms described above; or affecting your sleep, work or daily life to the point where you are considering stopping treatment. Stopping without clinical guidance risks losing the benefits you have already built, and there may be a straightforward adjustment that helps.
If you are not yet on treatment and want to understand whether Mounjaro could be clinically appropriate for you, a consultation with our prescribers is the first step. At nume, a real clinician reviews your answers the same day, your information goes to a prescriber's desk, not into an automated queue. You can learn more about our clinical team on the clinical team profile or read general treatment FAQs on the FAQs page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.